I’d be really interested in investing into this new IPO.
Me too, gene editing treatment for those with cholesterol problems caused by their genetics. Uses a ‘next gen’ CRISPR technology licensed from Beam Therapeutics. IPO was last week.
Would be very keen to have this stock on Freetrade as well!!
1 Like